These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1755842)
21. Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria. Onaga Y; Ido A; Uto H; Hasuike S; Kusumoto K; Moriuchi A; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H Biochem Biophys Res Commun; 2004 Sep; 321(4):851-8. PubMed ID: 15358105 [TBL] [Abstract][Full Text] [Related]
22. Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria. Di Pierro E; Brancaleoni V; Moriondo V; Besana V; Cappellini MD Clin Genet; 2007 Jan; 71(1):84-8. PubMed ID: 17204051 [TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of a novel defect occurring de novo associated with erythropoietic protoporphyria. Wang X Biochim Biophys Acta; 1996 Aug; 1316(3):149-52. PubMed ID: 8781532 [TBL] [Abstract][Full Text] [Related]
24. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria. Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836 [TBL] [Abstract][Full Text] [Related]
25. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review. Long ZB; Wang YW; Yang C; Liu G; Du YL; Nie GJ; Chang YZ; Han B J Zhejiang Univ Sci B; 2016 Oct.; 17(10):813-820. PubMed ID: 27704751 [TBL] [Abstract][Full Text] [Related]
26. Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients. Henriksson M; Timonen K; Mustajoki P; Pihlaja H; Tenhunen R; Peltonen L; Kauppinen R J Invest Dermatol; 1996 Feb; 106(2):346-50. PubMed ID: 8601739 [TBL] [Abstract][Full Text] [Related]
27. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria. Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946 [TBL] [Abstract][Full Text] [Related]
29. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria. Li C; Di Pierro E; Brancaleoni V; Cappellini MD; Steensma DP Clin Chem Lab Med; 2009; 47(1):44-6. PubMed ID: 19055472 [TBL] [Abstract][Full Text] [Related]
30. A genotype-phenotype correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria. Minder EI; Gouya L; Schneider-Yin X; Deybach JC Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):91-6. PubMed ID: 11929053 [TBL] [Abstract][Full Text] [Related]
31. Systematic screening for RNA with skipped exons--splicing mutations of the ferrochelatase gene. Wang X; Poh-Fitzpatrick M; Chen T; Malavade K; Carriero D; Piomelli S Biochim Biophys Acta; 1995 Jun; 1271(2-3):358-62. PubMed ID: 7541650 [TBL] [Abstract][Full Text] [Related]
32. Haplotype analysis in determination of the heredity of erythropoietic protoporphyria among Swiss families. Schneider-Yin X; Rüfenacht UB; Hergersberg M; Schnyder C; Deybach JC; Minder EI J Invest Dermatol; 2001 Dec; 117(6):1521-5. PubMed ID: 11886517 [TBL] [Abstract][Full Text] [Related]
33. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria. Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581 [TBL] [Abstract][Full Text] [Related]
34. Examination of ferrochelatase mutations that cause erythropoietic protoporphyria. Sellers VM; Dailey TA; Dailey HA Blood; 1998 May; 91(10):3980-5. PubMed ID: 9573038 [TBL] [Abstract][Full Text] [Related]
36. Decreased leukocyte ferrochelatase activity in erythropoietic protoporphyria. Kondo M; Ohe M; Mizuguchi M J Dermatol; 1989 Apr; 16(2):116-21. PubMed ID: 2778187 [TBL] [Abstract][Full Text] [Related]
37. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice. Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505 [TBL] [Abstract][Full Text] [Related]
38. Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure. Sarkany RP; Cox TM QJM; 1995 Aug; 88(8):541-9. PubMed ID: 7648240 [TBL] [Abstract][Full Text] [Related]
39. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Gouya L; Puy H; Robreau AM; Bourgeois M; Lamoril J; Da Silva V; Grandchamp B; Deybach JC Nat Genet; 2002 Jan; 30(1):27-8. PubMed ID: 11753383 [TBL] [Abstract][Full Text] [Related]
40. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria. Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]